Advertisement
Review Article|Articles in Press

Continuous Glucose Monitoring in Dogs and Cats

Application of New Technology to an Old Problem
Published:February 26, 2023DOI:https://doi.org/10.1016/j.cvsm.2023.01.008

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Behrend E.N.
        • Holford A.
        • Lathan P.
        • et al.
        2018 AAHA diabetes management guidelines for dogs and cats.
        J Am Anim Hosp Assoc. 2018; 54: 1-21
        • European Society of Veterinary Endocrinolgy
        ALIVE Project. Definition: treatment goals of diabetes mellitus.
        2021 (Available at:) (Accessed August 14, 2022)
        • Nelson R.W.
        Canine diabetes mellitus.
        in: Feldman E.C. Nelson R.W. Reusch C.E. Canine and feline endocrinology. 4th edition. Elsevier Saunders, St Louis, MO2015: 213-253
        • Reusch C.E.
        Feline diabetes mellitus.
        in: Feldman E.C. Nelson R.W. Reusch C.E. Canine and feline endocrinology. 4th edition. Elsevier Saunders, St Louis, MO2015: 258-308
        • Wiedmeyer C.E.
        • DeClue A.E.
        Continuous glucose monitoring in dogs and cats.
        J Vet Intern Med. 2008; 22: 2-8
        • Reusch C.E.
        • Kley S.
        • Casella M.
        Home monitoring of the diabetic cat.
        J Feline Med Surg. 2006; 8: 119-127
        • Alt N.
        • Kley S.
        • Haessig M.
        • et al.
        Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus.
        J Am Vet Med Assoc. 2007; 230: 1011-1017
        • Fleeman L.M.
        • Rand J.S.
        Evaluation of day-to-day variability of serial blood glucose concentration curves in diabetic dogs.
        J Am Vet Med Assoc. 2003; 222: 317-321
        • Cook A.K.
        Monitoring methods for dogs and cats with diabetes mellitus.
        J Diabetes Sci Technol. 2012; 6: 491-495
        • Mazze R.
        Advances in glucose monitoring: improving diabetes management through evidence-based medicine.
        Prim Care Diabetes. 2020; 14: 515-521
        • Cappon G.
        • Vettoretti M.
        • Sparacino G.
        • et al.
        Continuous Glucose Monitoring Sensors for Diabetes Management: a review of technologies and applications.
        Diabetes Metab J. 2019; 43: 383-397
        • Didyuk O.
        • Econom N.
        • Guardia A.
        • et al.
        Continuous Glucose Monitoring Devices: past, present, and future focus on the history and evolution of technological innovation.
        J Diabetes Sci Technol. 2021; 15: 676-683
        • Mazze R.S.
        • Strock E.
        • Borgman S.
        • et al.
        Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): Is CGM ready for real time?.
        Diabetes Technol Ther. 2009; 11: 11-18
        • Mazze R.S.
        • Strock E.
        • Wesley D.
        • et al.
        Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile (AGP) analysis.
        Diabetes Technol Ther. 2008; 10: 149-159
        • Aronson R.
        • Abitbol A.
        • Tweden K.S.
        First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes.
        Diabetes Obes Metab. 2019; 21: 1689-1694
        • Cappon G.
        • Acciaroli G.
        • Vettoretti M.
        • et al.
        Wearable continuous glucose monitoring sensors: a revolution in diabetes treatment.
        Electronics. 2017; 6: 65
        • Gerritsen M.
        • Jansen J.A.
        • Kros A.
        • et al.
        Influence of inflammatory cells and serum on the performance of implantable glucose sensors.
        J Biomed Mater Res. 2001; 54: 69-75
        • Heinemann L.
        on behalf of the Glucose Monitoring Group. Continuous glucose monitoring by means of the microdialysis technique: underlying fundamental aspects.
        Diabetes Technol Ther. 2003; 5: 545-561
        • Rebrin K.
        • Steil G.M.
        Can interstitial glucose assessment replace blood glucose measurements?.
        Diabetes Technol Ther. 2000; 2: 461-472
        • Sternberg F.
        • Meyerhoff C.
        • Mennel F.J.
        • et al.
        Subcutaneous glucose concentration in humans. Real estimation and continuous monitoring.
        Diabetes Care. 1995; 18: 1266-1269
        • Rebrin K.
        • Steil G.M.
        • Van Antwerp W.P.
        • et al.
        Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring.
        Am J Phys. 1999; 277: 561-571
        • Moretti S.
        • Tschuor F.
        • Osto M.
        • et al.
        Evaluation of a novel real-time continuous glucose-monitoring system for use in cats.
        J Vet Intern Med. 2010; 24: 120-126
        • Del Baldo F.
        • Fracassi F.
        • Pires J.
        • et al.
        Accuracy of a flash glucose monitoring system in cats and determination of the time lag between blood glucose and interstitial glucose concentrations.
        J Vet Intern Med. 2021; 35: 1279-1287
        • Chen C.
        • Zhao X.L.
        • Li Z.H.
        • et al.
        Current and emerging technology for continuous glucose monitoring.
        Sensors. 2017; 17: 182
        • Dehennis A.
        • Mortellaro M.A.
        • Ioacara S.
        Multisite study of an implanted continuous glucose sensor over 90 days in patients with diabetes mellitus.
        J Diabetes Sci Technol. 2015; 9: 951-996
        • Wiedmeyer C.E.
        • Johnson P.J.
        • Cohn L.A.
        • et al.
        Evaluation of a continuous glucose monitoring system for use in veterinary medicine.
        Diabetes Technol Ther. 2005; 7: 885-895
        • Surman S.
        • Fleeman L.
        Continuous glucose monitoring in small animals.
        Vet Clin North Am Small Anim Pract. 2013; 43: 381-406
        • Davison L.J.
        • Slater L.A.
        • Herrtage M.E.
        • et al.
        Evaluation of a continuous glucose monitoring system in diabetic dogs.
        J Small Anim Pract. 2003; 44: 435-442
        • Ristic J.M.
        • Herrtage M.E.
        • Walti-Lauger S.M.
        • et al.
        Evaluation of a continuous glucose monitoring system in cats with diabetes mellitus.
        J Feline Med Surg. 2005; 7: 153-162
        • Affenzeller N.
        • Benesch T.
        • Thalhammer J.G.
        • et al.
        A pilot study to evaluate a novel subcutaneous continuous glucose monitoring system in healthy Beagle dogs.
        Vet J. 2010; 184: 105-110
        • Salesov E.
        • Zini E.
        • Riederer A.
        • et al.
        Comparison of the pharmacodynamics of protamine zinc insulin and insulin degludec and validation of the continuous glucose monitoring system iPro2 in healthy cats.
        Res Vet Sci. 2018; 118: 79-85
        • Corradini S.
        • Pilosio B.
        • Dondi F.
        • et al.
        Accuracy of flash glucose monitoring system in diabetic dogs.
        J Vet Intern Med. 2016; 30: 983-988
        • Tardo A.M.
        • Irace C.
        • Del Baldo F.
        • et al.
        Clinical use of a 180-day implantable glucose monitoring system in dogs with diabetes mellitus: a case series.
        Animals (Basel). 2022; 12: 860
        • Reineke E.L.
        • Fletcher D.J.
        • King L.G.
        • et al.
        Accuracy of a continuous glucose monitoring system in dogs and cats with diabetic ketoacidosis.
        J Vet Emerg Crit Care. 2010; 20: 303-312
        • Koenig A.
        • Hoenig M.E.
        • Jimenez D.A.
        Effect of sensor location in dogs on performance of an interstitial glucose monitor.
        Am J Vet Res. 2016; 77: 805-817
        • Hafner M.
        • Lutz T.A.
        • Reusch C.E.
        • et al.
        Evaluation of sensor sites for continuous glucose monitoring in cats with diabetes mellitus.
        J Feline Med Surg. 2013; 15: 117-123
        • Hoss U.
        • Erwin S.B.
        • Hanqing L.
        • et al.
        Feasibility of factory calibration for subcutaneous glucose sensors in subjects with diabetes.
        J Diabetes Sci Technol. 2014; 8: 89-94
      1. Berg AS, Crews CD, Castro AA, et al. Assessment of the FreeStyle Libre 2 interstitial glucose monitor in hypo- and euglycemia in Cats. Paper presented at the 2022 ACVIM Congress; June 23–25 2022; Austin, Texas.

        • Malerba E.
        • Cattani C.
        • Del Baldo F.
        • et al.
        Accuracy of flash glucose monitoring system in dogs with diabetic ketoacidosis.
        J Vet Intern Med. 2020; 34: 83-91
        • Del Baldo F.
        • Canton C.
        • Testa S.
        • et al.
        Comparison between a flash glucose monitoring system and a portable blood glucose meter for monitoring dogs with diabetes mellitus.
        J Vet Intern Med. 2020; 34: 2296-2305
        • Silva D.D.
        • Cecci G.R.M.
        • Biz G.
        • et al.
        Evaluation of a flash glucose monitoring system in dogs with diabetic ketoacidosis.
        Domest Anim Endocrinol. 2021; 74: 106525
        • Shea E.K.
        • Hess R.S.
        Assessment of postprandial hyperglycemia and circadian fluctuation of glucose concentrations in diabetic dogs using a flash glucose monitoring system.
        J Vet Intern Med. 2021; 35: 843-852
        • Howard L.A.
        • Lidbury J.A.
        • Jeffery N.
        • et al.
        Evaluation of a flash glucose monitoring system in nondiabetic dogs with rapidly changing blood glucose concentrations.
        J Vet Intern Med. 2021; 35: 2628-2635
      2. BSI Standards Publication, In vitro diagnostic test systems –Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (EN ISO 15197:2013). Avaiable at: https://www.iso.org/standard/54976.html. Accessed February 18, 2023.

        • Del Baldo F.
        • Diana A.
        • Canton C.
        • et al.
        The Influence of Skin Thickness on Flash Glucose Monitoring System Accuracy in Dogs with Diabetes Mellitus.
        Animals (Basel). 2021; 11: 408
        • Deiting V.
        • Mischke R.
        Use of the "FreeStyle Libre" glucose monitoring system in diabetic cats.
        Res Vet Sci. 2021; 135: 253-259
        • Shea E.K.
        • Hess R.S.
        Validation of a flash glucose monitoring system in outpatient diabetic cats.
        J Vet Intern Med. 2021; 35: 1703-1712
        • Knies M.
        • Teske E.
        • Kooistra H.
        Evaluation of the FreeStyle Libre, a flash glucose monitoring system, in client-owned cats with diabetes mellitus.
        J Feline Med Surg. 2022; 24: 223-231
        • Shoelson A.M.
        • Mahony O.M.
        • Pavlick M.
        Complications associated with a flash glucose monitoring system in diabetic cats.
        J Feline Med Surg. 2021; 23: 557-562
        • Deiss D.
        • Szadkowska A.
        • Gordon D.
        • et al.
        Clinical practice recommendations on the routine use of Eversense, the first long-term implantable continuous glucose monitoring system.
        Diabetes Technol Ther. 2019; 21: 254-264
        • Irace C.
        • Cutruzzolà A.
        • Nuzzi A.
        • et al.
        Clinical use of a 180-day implantable glucose sensor improves glycated hemoglobin and time in range in patients with type 1 diabetes.
        Diabetes Obes Metab. 2020; 22: 1056-1061
        • Kropff J.
        • Choudhary P.
        • Neupane S.
        • et al.
        Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: a 180-day, prospective, multicenter, pivotal trial.
        Diabetes Care. 2017; 40: 63-68
      3. Senseonics Inc. Eversense XL user guide.
        (Available at) (Accessed August 15, 2022)
        • Benkhadra K.
        • Alahdab F.
        • Tamhane S.
        • et al.
        Real-time con- tinuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis.
        Clin Endocrinol. 2017; 86: 354-360
        • Dicembrini I.
        • Cosentino C.
        • Monami M.
        • et al.
        Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
        Acta Diabetol. 2021; 58: 401-410
        • Haak T.
        • Hanaire H.
        • Ajjan R.
        • et al.
        Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial.
        Diabetes Ther. 2017; 8: 55-73
        • Jamiolkowska M.
        • Jamiolkowska I.
        • Luczynski W.
        • et al.
        Impact of real-time continuous glucose monitoring use on glucose variability and endothelial function in adolescents with type 1 diabetes: new technology. New possibility to decrease cardiovascular risk?.
        J Diabetes Res. 2016; 2016: 4385312
        • Tumminia A.
        • Crimi S.
        • Sciacca L.
        • et al.
        Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
        Diabetes Metab Res Rev. 2015; 31: 61-68
        • Rusak E.
        • Ogarek N.
        • Wolicka K.
        • et al.
        The Quality of life and satisfaction with continuous glucose monitoring therapy in children under 7 years of age with T1D using the rtCGM system integrated with insulin pump-A caregivers point of view.
        Sensors. 2021; 21: 3683
        • Dietiker-Moretti S.
        • Müller C.
        • Sieber-Ruckstuhl N.
        • et al.
        Comparison of a continuous glucose monitoring system with a portable blood glucose meter to determine insulin dose in cats with diabetes mellitus.
        J Vet Intern Med. 2011; 25: 1084-1088
        • Mori A.
        • Kurishima M.
        • Oda H.
        • et al.
        Comparison of glucose fluctuations between day- and night-time measured using a continuous glucose monitoring system in diabetic dogs.
        J Vet Med Sci. 2013; 75: 113-117
        • Suh S.
        • Kim J.H.
        Glycemic variability: how do we measure it why is it important?.
        Diabetes Metab J. 2015; 39: 273-382
        • Reusch C.E.
        • Salesov E.
        Monitoring diabetes in cats.
        in: Feldman E.C. Fracassi F. Peterson M. Feline endocrinology. 1st edition. Edra s.p.a., Milano2019: 522-539
        • Frontoni S.
        • Di Bartolo P.
        • Avogaro A.
        • et al.
        Glucose variability: an emerging target for the treatment of diabetes mellitus.
        Diabetes Res Clin Pract. 2013; 102: 86-95
        • Brownlee M.
        • Hirsch I.B.
        Glycemic variability: a hemoglobin A1c- independent risk factor for diabetic complications.
        JAMA. 2006; 295: 1707-1708
        • Umpierrez G.E.
        • Kovatchev B.P.
        Glycemic variability: how to measure and its clinical implication for type 2 diabetes.
        Am J Med Sci. 2018; 356: 518-527
        • Lachin J.M.
        • Genuth S.
        • Nathan D.M.
        • et al.
        for the DCCT/EDIC Research Group. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial-revisited.
        Diabetes. 2008; 57: 995-1001
        • Zinman B.
        • Marso S.P.
        • Christiansen E.
        • et al.
        Day-today fasting glycemic variability in DEVOTE: associations with severe hypoglycemia and cardiovascular outcomes (DEVOTE 2).
        Diabetologia. 2018; 61: 48-57
        • Lin C.C.
        • Yang C.P.
        • Li C.I.
        • et al.
        Visit-to-visit variability of fasting plasma glucose as a predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan diabetes study.
        BMC Med. 2014; 26: 165
        • Zini E.
        • Salesov E.
        • Dupont P.
        • et al.
        Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats.
        J Vet Intern Med. 2018; 32: 978-985
        • Krämer A.L.
        • Riederer A.
        • Fracassi F.
        • et al.
        Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release.
        J Vet Intern Med. 2020; 34: 2287-2295
        • Linari G.
        • Fleeman L.
        • Gilor C.
        • et al.
        Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus.
        J Feline Med Surg. 2022; 24: 168-176
        • Niessen S.J.
        • Forcada Y.
        • Mantis P.
        • et al.
        Studying cat (Felis catus) diabetes: beware of the acromegalic imposter.
        PLoS One. 2015; 10: e0127794
        • Evans M.
        • Welsh Z.
        • Ells S.
        • et al.
        The impact of flash glucose monitoring on glycaemic control as measured by hba1c: a meta-analysis of clinical trials and real-world observational studies.
        Diabetes Ther. 2020; 11: 83-95
        • Mori H.
        • Okada Y.
        • Kurozumi A.
        • et al.
        Factors influencing inter-day glycemic variability in diabetic outpatients receiving insulin therapy.
        J Diabetes Investig. 2017; 8: 69-74
      4. Re M, Del Baldo F, Tardo AM, et al. Monitoring of diabetes mellitus with Flash Glucose Monitoring System: the owners’ point of view. Paper presented at the 32nd ECVIM-CA Congress; September 1–3 2022; Gothenburg, Sweden.

        • Evans M.
        • Cranston I.
        • Bailey C.J.
        Ambulatory glucose profile (AGP): utility in UK clinical practice.
        Br J Diabetes. 2017; 17: 28-33
        • Bergenstal R.M.
        • Ahmann A.J.
        • Bailey T.
        • et al.
        Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile.
        J Diabetes Sci Technol. 2013; 7: 562-578
        • Battelino T.
        • Danne T.
        • Bergenstal R.M.
        • et al.
        Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range.
        Diabetes Care. 2019; 42: 1593-1603
        • Bergenstal R.M.
        • Beck R.W.
        • Close K.L.
        • et al.
        Glucose management indicator (GMI): A new term for estimating A1C from continuous glucose monitoring.
        Diabetes Care. 2018; 41: 2275-8220
        • Del Baldo F.
        • Tardo A.M.
        • Alessandrini F.
        • et al.
        The usefulness of different freestyle libre-derived metrics in assessing glycemic control in diabetic dogs.
        J Vet Intern Med. 2021; 35: 3115